Drs. Henriette Jansen (IPS Secretary), Dr. Tom Sam (IPS President) and Dr. Claudia Rijcken (IPS Communications Manager) during the Speakers dinner in Sao Paulo, Brazil, 2006.

Mr. C. Liu (International Affairs, CPA), Dr. Li Shaoli (Secretary General, CPA), Director J. Zhang (GD-FDA) and FIP-IPS Congress Chair Prof. Dr. Adel Sakr (USA) during the Annual Chinese Pharmaceutical Association Congress, Guangzhou, November 2006.

Prof. Dr. Adel Sakr is the Director of the Industrial Pharmacy Graduate Program at the College of Pharmacy, University of Cincinnati Medical Center, Cincinnati, USA. He has 40 years of international academic and industrial experiences, more than 146 internationally published research papers; and presented more than 350 conference presentations, invited presentations and /or workshops. Professor Sakr is an elected Fellow of AAPS and Graduate Fellow of the University of Cincinnati. He is the recipient of the Distinguished Faculty Achievement Award of the University of Cincinnati and has been awarded DOCTOR HONORIS CAUSA in the year 2000. Dr. Sakr is Congress Chair, FIP-Industrial Pharmacy Section.

Adel Sakr 教授,美国辛辛那提大学医学部药学院工业药学系主任(美国)。

Dr. Tom Sam is currently Director Global Regulatory CMC, NV Organon, the Netherlands. He was head of Organon’s Pharmaceutics “Novel Dosage Forms” and “Solid Dosage Forms” Sections for many years. He is president of FIP’s Industrial Pharmacy Section, member of the WHO Expert Committee on Specifi cations of Pharmaceutical Preparations, moderator of the Quality module of the European Regulatory Affairs course, and organizer of the European Symposia on Controlled Drug Delivery. He is a member of the AAPS focus groups Regulatory Science and Manufacturing/Engineering & Quality.

Tom Sam 博士,ORGANON 公司全球法规部的主任 (荷兰)。

Dr. Claudia Rijcken is a pharmacist by training and in 2003 she finished her Ph.D. within the field of schizophrenia research. Dr. Rijcken additionally acquired an executive MBA in health administration. After working for several years as managerial head of a community pharmacy, in 2005 she switched to industrial pharmacy. She started within the Dutch company Organon as a study director for global clinical trials in the realm of Neuroscience. Currently, she is employed as Expert Clinical Manager at Novartis, Switzerland. Dr. Rijcken is member of the ExCo of the Industrial Pharmacy Section of FIP and board member of the Dutch Industrial Pharmacists Association.

Claudia Rijcken 博士 NOVARTIS 公司神经科学全球临床试验部门任研究主任和神经科学的医学顾问(荷兰)。

Prof. Dr. Michael Anisfeld is a senior consultant for Globepharm Consulting specializing in GMP/Quality activities for the healthcare manufacturing industries. In his current position he numbers among his clients United Nations Agencies (WHO, UNFPA, UNICEF, UNIDO), national regulatory agencies (including the Chinese SFDA, US-FDA, Australian TGA) and over 260 pharmaceutical, medical device, biotechnology and bulk pharmaceutical companies in the Americas, Africa, Europe and Asia.

Michael Anisfeld 博士教授,医疗生产企业GMP和质量管理的全球咨询高级顾问 (美国)。

Dr. Mathew Cherian is Director of Pharmaceutical Development Services for Patheon Inc, a world leader in pharmaceutical development and manufacturing services for the pharmaceutical industry. He has over 22 years of experience in pharmaceutical R&D. Trained as a chemical engineer, Dr. Cherian has held leadership positions in sterile product development at leading pharmaceutical companies like Pharmacia and Pfi zer. His interests include aseptic processing, lipid- based drug delivery and biologics. He has several patents, publications and presentations to his credit. Dr. Cherian is a member of the American Institute of Chemical Engineers, American Association of Pharmaceutical Scientists, and Controlled Release Society.

Mathew Cherian 博士,PATHEON 公司制剂开发部的主任(意大利)。

Mr. Chunguang Liu, Director International Affairs Department, Chinese Pharmaceutical Association.

Email: sinopharmacy@163.net or Icg@cpa.org.cn
Tel: 86 10 58699271; Fax: 86 10 58699272

刘春光先生,中国药学会国际部主任(中国)。

Director Jing Hua Zhang is the Deputy Director of Guangdong Food and Drug Administration in charge of anti-counterfeit and product registration. He is also the National GMP Inspector of China State Food and Drug Administration. Mr. Zhang used to be visiting Scholar in California State University Sacramento USA major in Executive Management and drug administration Regulations. He also participated in Pharmacovigilance training Course “WHO-UMC at TGA” in Canberra, Australia. In the past 8 years or more Mr. Zhang had made big effort in promoting the internalization of China pharmaceutical industry and achieved big progress in pharmaceutical development for Guangdong province.

张京华,广东省食品药品监督管理局副局长 (中国)。

Prof. Dr. Xinyong Liu is currently a professor at the Institute of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University. His research work is partly engaged in the design and synthesis of a variety of molecules targeted at the specifi c enzymes and receptors. At present time, He is focusing on the design and synthesis of novel HIV-1 non- nucleoside reverse transcriptase inhibitors, as well as the design and synthesis of new HIV- 1 transactivation inhibitors based on HIV-1Tat-TAR interaction in the viral transcription step. His second ongoing program is synthesis of some natural products from Chinese Traditional Medicine active in cerebro/cardio vascular biology.

刘新泳博士,山东大学药学院院长助理,药物化学教授 (中国)。

Prof. Dr. Wan-Liang Lu is Deputy Chairman of Department of Pharmaceutics at School of Pharmaceutical Sciences, Peking University. He was Scientist at National University of Singapore, International Medical Center of Johns Hopkins Singapore, and Toyama University. His research on pharmaceutics and pharmacokinetics resulted in 80 research papers, more than 10 book chapters, and patent applications.

吕万良教授,北京大学药学院药剂系副主任(中国)。

Prof. Guoan Luo is Director of Modern Research Center of Traditional Chinese Medicine, Tsinghua University, Member of State Pharmacopeia Commission and Associate Editor-in- chief of the Pharmacopoeia of P.R.China. His research interests are focused on the Traditional Chinese Medicine and bio-analytical chemistry. Till now, Prof. Luo has published more than 440 peer-reviewed papers, fi led 30 patents and obtained over 10 National or provincial awards for his achievements in science and technology.

罗国安教授,清华大学传统中医药现代研究中心主任 (中国)。

Prof. Dr. Wen-fang Xu is a distinguished Professor of Shandong University, Standing Dean and Director of Institute of Medicinal Chemistry of School of Pharmaceutical Sciences Shandong University. In his current position he numbers among his clients National Anticancer Society for Anticancer Agent Division, SFDA for New Drugs Evaluation Committee, National Pharmaceutical Society for Medicinal Chemistry Division, Associate Chief Member Chinese Ministry of Ein China.

徐文方博士教授,山东大学药学院常务副院长,药物化学教授 (中国)。